Studies in three different transgenic mouse models suggest that the amyloid
beta -protein contributes to memory loss in Alzheimer disease. Immunizatio
n with an amyloid beta -peptide fragment reduces learning and memory impair
ments in mice, and this approach may eventually be used to prevent and/or t
reat this disease in people.